0 Yorumlar
0 hisse senetleri
941 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Asia-Pacific Biologics Market Revenue Forecast: Growth, Share, Value, and Trends"Asia-Pacific Biologics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2030 The APAC Biopharmaceuticals Market is witnessing strong growth across multiple sectors, including [industry name], where demand is rising due to innovation and market expansion. Market research data indicates that businesses in the Biotechnology Drug Industry are...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Autoimmune Encephalitis Treatment Market is driven by Rising Biologics InvestmentThe Autoimmune Encephalitis (AIE) Treatment Market encompasses therapies and interventions designed to address the immune-mediated inflammation of the brain. Key products in this space include corticosteroids, intravenous immunoglobulins (IVIG), plasmapheresis systems, and emerging targeted biologics that modulate specific immune pathways. These treatment options offer advantages such as rapid...0 Yorumlar 0 hisse senetleri 967 Views 0 önizleme
-
Biologics and Immunotherapies Transform Immune-Mediated Inflammatory Diseases Market"Executive Summary Immune-Mediated Inflammatory Diseases Market : CAGR Value Data Bridge Market Research analyses a growth rate in the global immune-mediated inflammatory diseases market in the forecast period 2022-2029. The Immune-Mediated Inflammatory Diseases Market report offers a great understanding of the current market situation with the historic and upcoming market...0 Yorumlar 0 hisse senetleri 441 Views 0 önizleme
-
Biologics CDMO Market Size 2034The Biologics Contract Development and Manufacturing Organization (CDMO) market is experiencing robust growth, driven by increasing demand for biologics, biosimilars, and advanced therapeutic modalities. Below is a comprehensive overview of the market, including recent developments, key drivers and restraints, regional analysis, emerging trends, top use cases, major challenges, attractive...0 Yorumlar 0 hisse senetleri 753 Views 0 önizleme
-
Biologics Drive Global Growth in Protein Therapeutics Market"Executive Summary Protein Therapeutics Market : CAGR Value Data Bridge Market Research analyses that the protein global therapeutics market which was USD 115.17 billion in 2022, is expected to reach USD 290.74 billion by 2030, and is expected to undergo a CAGR of 6.68% during the forecast period 2023-2030. The study and analysis conducted in this industry report also helps to...0 Yorumlar 0 hisse senetleri 458 Views 0 önizleme
-
Biologics Fill Finish Manufacturing Market Driven by Biopharma GrowthThe Biologics Fill Finish Manufacturing Market encompasses specialized processes and technologies used to aseptically fill and package biologic drugs, including monoclonal antibodies, vaccines, and recombinant proteins. This critical segment of biopharmaceutical production ensures product integrity, sterility, and accurate dosing, leveraging advanced isolators, lyophilizers, and single-use...0 Yorumlar 0 hisse senetleri 799 Views 0 önizleme
-
Biopharmacy Market Expands Amid Increasing Biologics and Personalized Medicine Demand"Biopharmacy Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2029 The Biotechnology Pharmaceuticals Market is experiencing rapid transformation, driven by technological advancements, evolving consumer preferences, and industry innovations. According to top market research companies, businesses across sectors are leveraging in-depth insights to...0 Yorumlar 0 hisse senetleri 743 Views 0 önizleme
-
Biosimilar and Biologics Market : Size, Trends, and Growth Analysis 2032The Biosimilar and Biologics Market is undergoing a seismic shift as demand for affordable, effective treatments continues to surge worldwide. With innovations in biotechnology, growing cases of chronic and autoimmune diseases, and the looming expiration of several high-profile biologic drug patents, both biologics and their biosimilar counterparts are redefining how modern medicine is...0 Yorumlar 0 hisse senetleri 361 Views 0 önizleme
-
Biosimilars and Follow-On Biologics Market Opportunities 2025-2033According to FutureWise analysis, the market for biosimilars and follow-on biologics in 2023 is US$26.03 billion, and is expected to reach US$83.69 billion by 2031 at a CAGR of 15.70%. Biosimilars are biological products designed to be highly similar to an already approved (licensed) drug, known as the reference product, as determined by regulatory authorities such as the Food and Drug...0 Yorumlar 0 hisse senetleri 197 Views 0 önizleme
-
Chronic Idiopathic Urticaria (CIU) Treatment Market Fueled by Biologics GrowthThe global Chronic Idiopathic Urticaria (CIU) Treatment Market encompasses a broad spectrum of therapeutic interventions designed to mitigate the persistent hives and severe itching characteristic of CIU. First‐line treatments primarily involve second‐generation H1‐antihistamines, which offer rapid symptom relief and a favorable safety profile compared to first‐generation counterparts,...0 Yorumlar 0 hisse senetleri 747 Views 0 önizleme
-
Global Bioengineered Protein Drugs Market: Opportunities in BiologicsAccording to FutureWise analysis, the market for bioengineered protein drugs in 2023 is US$383.21 billion, and is expected to reach US$720.93 billion by 2031 at a CAGR of 8.22%. The bioengineered protein drugs market is anticipated to witness significant growth, projected to increase from approximately USD 383 billion in 2023 to an estimated USD 721 billion by 2031, with a compound annual...0 Yorumlar 0 hisse senetleri 535 Views 0 önizleme
-
Global Immunocytokines Market is driven by cancer immunotherapy demandImmunocytokines are innovative fusion proteins that couple the targeting ability of monoclonal antibodies with the immune-activating properties of cytokines. These bioconjugates enable precise delivery of cytokines to tumor sites, reducing off-target toxicity while enhancing T-cell proliferation and antitumor responses. Key advantages include improved therapeutic index, synergistic action with...0 Yorumlar 0 hisse senetleri 808 Views 0 önizleme
-
Lupus Nephritis Treatment Market Driven by Biologics AdoptionLupus Nephritis Treatment Market products include a range of immunosuppressants, corticosteroids, antimalarials, and cutting-edge biologic therapies designed to suppress autoimmune activity and protect renal function. These therapies offer significant advantages such as targeted action, reduced systemic side effects, and improved long-term outcomes for patients suffering from renal inflammation...0 Yorumlar 0 hisse senetleri 607 Views 0 önizleme
-
Lupus Therapeutic Market Trends, Opportunities, and Growth ForecastExecutive Summary Lupus Therapeutic Market Opportunities by Size and Share CAGR Value Global lupus therapeutic market size was valued at USD 3.32 billion in 2024 and is projected to reach USD 6.67 billion by 2032, with a CAGR of 9.10% during the forecast period of 2025 to 2032. An international Lupus Therapeutic Market report lends a hand to identify how the market is going to...0 Yorumlar 0 hisse senetleri 318 Views 0 önizleme
-
Propionic Acidemia Therapeutic Market is driven by Gene Therapy AdvancementsPropionic acidemia is a rare, inherited metabolic disorder characterized by a deficiency of the propionyl-CoA carboxylase enzyme, leading to toxic metabolite buildup. Therapeutic solutions in this market range from dietary management products and amino acid formulae to innovative enzyme replacement and gene therapy candidates. These products aim to reduce propionate accumulation, stabilize...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Protein Therapeutics Market Grows Globally with Rising Biopharma Innovation and Demand for Targeted Therapies"Executive Summary Protein Therapeutics Market : CAGR Value Data Bridge Market Research analyses that the protein global therapeutics market which was USD 115.17 billion in 2022, is expected to reach USD 290.74 billion by 2030, and is expected to undergo a CAGR of 6.68% during the forecast period 2023-2030. Comprehensive data and brilliant forecasting techniques used in...0 Yorumlar 0 hisse senetleri 382 Views 0 önizleme
-
Secukinumab Market Expands on the Back of Increasing Autoimmune Disorder Cases"Executive Summary Secukinumab Market : CAGR Value Secukinumab market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.80% in the above mentioned forecast period. All the data and information mentioned in this Secukinumab Market report assists businesses take superior...0 Yorumlar 0 hisse senetleri 451 Views 0 önizleme
Arama Sonuçları